u 74006f has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baethmann, A; Hungerhuber, E; Reulen, HJ; Schmid-Elsaesser, R; Zausinger, S | 2 |
2 other study(ies) available for u 74006f and Weight Gain
| Article | Year |
|---|---|
Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
Topics: Animals; Calcium Channel Blockers; Cerebral Infarction; Dextromethorphan; Drug Evaluation, Preclinical; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Neuroprotective Agents; Pregnatrienes; Rats; Rats, Sprague-Dawley; Treatment Outcome; Weight Gain | 1998 |
Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia.
Topics: Animals; Basal Ganglia; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Drug Therapy, Combination; Electroencephalography; Hypothermia, Induced; Laser-Doppler Flowmetry; Magnesium Chloride; Male; Neuroprotective Agents; Pregnatrienes; Rats; Rats, Sprague-Dawley; Weight Gain | 1999 |